The FDA is seeking feedback on a list of patient preference areas that it put together to help them take into account patients’ views as they make regulatory decisions about medical devices. Included on this list of patient preference areas is “Ear, Nose, and Throat: Treatments for moderate to severe hearing loss (implanted hearing devices vs. other treatment options).”
The FDA is seeking information or qualitative or quantitative assessments of whether patients prefer certain alternatives, outcomes or choices over others in terms of their health.
The FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risks and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Check out their request for comments on the Federal Register.
Recent Posts
Q4 SPAN Meeting to Focus on the ASLP-IC Compact
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting on October 28, 2026, from 8:00–9:00 pm ET. The meeting…
Tympanostomy Tubes Found in the Middle Ear Space: A Case Report
The placement of pressure equalization (PE) tubes is common procedure and often used for management of otitis media with effusion (OME), recurrent acute otitis media…
Cochlear Implant SatisfactionÂ
Approximately 118,000 adults and 65,000 children in the United States have cochlear implants (CI) (National Institutes of Health, 2021). Most CIs require an external processor,…



